financetom
Business
financetom
/
Business
/
Exclusive-Kioxia market value set at $5 billion, Japan chipmaker to receive listing approval, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-Kioxia market value set at $5 billion, Japan chipmaker to receive listing approval, sources say
Nov 20, 2024 11:11 PM

TOKYO (Reuters) - Bain-backed Kioxia will have a market value of about 750 billion yen ($4.84 billion) based on the indicative price for its initial public offering, with the chipmaker to receive listing approval from the Tokyo bourse on Friday, two sources said.

The market value, which Reuters is reporting for the first time, could change depending on the final price in the IPO.

Kioxia, Bain and the Tokyo Stock Exchange declined to comment. The sources declined to be named as the information is not public.

Bain Capital scrapped plans for an IPO of Kioxia in October after investors pushed the buyout firm to almost halve the 1.5 trillion yen valuation it was seeking, Reuters has reported.

Kioxia is the first to choose to operate under new rules in Japan that allow companies to file a registration statement and communicate with investors before receiving listing approval.

Kioxia, formerly Toshiba Memory, is targeting a December IPO, Reuters has reported. Bain postponed a previous IPO plan for Kioxia four years ago.

Going public would offer Kioxia fundraising options in a capital intensive industry but increase scrutiny on the company's financials.

A Bain-led consortium acquired the chipmaker from scandal-hit conglomerate Toshiba for 2 trillion yen in 2018.

Shareholders including Bain will sell shares in the IPO, the sources said.

Morgan Stanley, Nomura and BofA Securities are joint global coordinators for the IPO.

($1 = 155.0400 yen)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cassava Sciences Advances Alzheimer's Drug Through High-Stakes Phase 3 Trials
Cassava Sciences Advances Alzheimer's Drug Through High-Stakes Phase 3 Trials
Jul 22, 2024
On Monday, Rick Barry, the executive chairman of Cassava Sciences ( SAVA ) Inc , wrote a letter to shareholders and employees. He said the company is in the final stages of testing its Alzheimer’s drug candidate, simufilam, with significant financial and emotional stakes. The company is conducting Phase 3 trials to demonstrate the drug’s efficacy and safety. Related: Alzheimer’s-Focused...
SunPower Stock Attempts To Bounce Back: What's Going On?
SunPower Stock Attempts To Bounce Back: What's Going On?
Jul 22, 2024
SunPower Corporation ( SPWR ) shares are volatile Monday. The stock tumbled last week after the company halted shipments and solar installations. The Details: SunPower shares fell more than 70% last week after the company informed clients it was halting product shipments and deactivating lease and power purchase agreements. SunPower cited its efforts to address financial challenges as the reason...
QXO Offers $620 Million of Shares in Private Placement
QXO Offers $620 Million of Shares in Private Placement
Jul 22, 2024
02:05 PM EDT, 07/22/2024 (MT Newswires) -- QXO (QXO) said Monday that it is offering $620 million of shares through a private placement with institutional and accredited investors. Under the terms of the deal, the company is selling around 67.8 million common shares at $9.14 per share. QXO said the private placement includes a $150 million investment from Affinity Partners....
PyroGenesis Completes $2.8 Million Private Placement of Share Units
PyroGenesis Completes $2.8 Million Private Placement of Share Units
Jul 22, 2024
02:08 PM EDT, 07/22/2024 (MT Newswires) -- PyroGenesis Canada ( PYRGF ) on Monday said it closed a non-brokered private placement of share units that raised $2.8-million. The company said it placed 3.51-million units in the financing, with each priced at $0.80 and made up of a share and a one-year warrant to buy a second for for $1.20. Peter...
Copyright 2023-2025 - www.financetom.com All Rights Reserved